ERASER Insecticide

SECTION 2: Hazards identification

dizziness, drowsiness, and incoordination. EMERGENCY OVERVIEW SYSTEMIC (OTHER TARGET ORGAN) EFFECTS: Hazardous Chemical. Hazardous Chemical. Red liquid with Excessive exposure may produce organophosphate type a solvent-type odor. May cause eye pain, irritation (which cholinesterase inhibition. Signs and symptoms of excessive may be slow to heal), or slight corneal injury. Vapors may exposure to chlorpyrifos may be headache, dizziness, irritate eyes. May cause skin irritation. LD50 for skin incoordination, muscle twitching, tremors, nausea, absorption in rabbits is >2000 mg/kg. Oral LD50 for female abdominal cramps, diarrhea, sweating, pinpoint pupils, rats is 272 mg/kg. The inhalation LC50 for rats is >1-1.7 blurred vision, salivation, tearing, tightness in chest, mg/L for 4 hours (males) and >4.65 mg/L for 1 hour excessive urination, and convulsions. Chlorpyrifos produced (females). Cholinesterase inhibitor. Flash Point is >220°F mild adrenal effects when fed to rats, but only at doses that (104°C) TCC and 205°F (96°C). Toxic to fish, wildlife, greatly exceeded any exposures that would be received avian and aquatic organisms. Product contains a petroleum during use of this product. Solvent has been reported to derivative solvent – will burn. cause liver, kidney and blood effects at high exposure levels. Xylene is reported to have caused hearing loss in laboratory animals upon exposure to high concentrations;

Potential health effects

This section includes such effects have not been reported in humans. For possible adverse effects, which could occur if this material is cumene, in animals, effects have been reported on the not handled in the recommended manner. following organs: eyes (cataracts).

Cancer information

Chlorpyrifos did not cause NOTE TO PHYSICIAN: Chlorpyrifos is a cholinesterase cancer in animal studies. inhibitor. Treat symptomatically. If exposed, plasma and red blood cell cholinesterase tests may indicate significance of TERATOLOGY (BIRTH DEFECTS): Chlorpyrifos did not exposure (baseline data are useful). Atropine, only by cause birth defects in laboratory animals. Solvent was toxic injection, is the preferable antidote. Oximes, such as to the fetus in laboratory animal tests, but only at doses that 2-PAM/protopam, may be therapeutic if used early; were toxic to the mothers. Very high concentrations of however, use only in conjunction with atropine. In case of solvent (producing severe toxicity to adult animals) induced severe acute poisoning, use antidote immediately after an increase in cleft palate in mice, which is a common establishing an open airway and respiration. Because rapid developmental abnormality in mice and is associated with absorption may occur through lungs if aspirated and cause stress to the maternal animals. No malformations were systemic effects, the decision of whether to induce vomiting induced at exposures less than those causing severe toxicity or not should be made by a physician. If lavage is to the adult animals. performed, endotracheal and/or esophageal control is suggested. Danger from lung aspiration must be weighed REPRODUCTIVE EFFECTS: Chlorpyrifos did not interfere against toxicity when considering emptying the stomach. with fertility in reproduction studies in laboratory animals. Exposure may increase "myocardial irritability". Do not Some evidence of toxicity to the offspring occurred, but only administer sympathomimetic drugs unless absolutely at a dose high enough to produce significant toxicity to the necessary. Supportive care. Treatment based on judgment parent animals. In a 3-generation reproduction study on the of the physician in response to reactions of the patient. solvent, the only effects observed were at exposures that produced severe toxicity to the parent animals. 5. FIRE FIGHTING MEASURES: